Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
4.4 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO FENTANYL TESTING STRIPS. | This Act authorizes the distribution of testing strips to determine the presence of fentanyl or fentanyl-related substances. Fentanyl testing strips could be distributed to the community along with opioid overdose reversal medication as a harm reduction strategy in the opioid addiction crisis. A number of states have authorized fentanyl testing strips distribution in recent years including Maryland, Rhode Island, the District of Columbia, and North Carolina. Twenty-seven states currently provide fentanyl testing strips through needle exchange programs. | us/states/de | Delaware General Assembly | 151 | SB 76 | Delaware SB 76 (151) |
|
enacted |
|
1 | 8 | 2 | 2021-03-04 | 2021-06-03 | openstates | ocd-bill/d85abf5f-969b-41ad-8842-e8aad1d9a2a1 | https://legis.delaware.gov/BillDetail?LegislationId=48404 | 4b1bd235be2e45d28be8c2b864fad52e2b884f256054ff2e89f2a93926a83045 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Delaware SB 76 (151) — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO FENTANYL TESTING STRIPS.
This Act authorizes the distribution of testing strips to determine the presence of fentanyl or fentanyl-related substances. Fentanyl testing strips could be distributed to the community along with opioid overdose reversal medication as a harm reduction strategy in the opioid addiction crisis. A number of states have authorized fentanyl testing strips distribution in recent years including Maryland, Rhode Island, the District of Columbia, and North Carolina. Twenty-seven states currently provide fentanyl testing strips through needle exchange programs.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Bill Text (committee substitute) — source
Votes
- SM — 40–0 (pass) · lower
- SM — 21–0 (pass) · upper
Sponsors
- Bryan Townsend — primary (person)
- David Bentz — primary (person)
- Laura V. Sturgeon — primary (person)
- Sarah McBride — primary (person)
- Stephanie L. Hansen — primary (person)
- Bruce C. Ennis — cosponsor (person)
- Dave G. Lawson — cosponsor (person)
- David P. Sokola — cosponsor (person)
- Eric Morrison — cosponsor (person)
- John L. Mitchell — cosponsor (person)
- Kyle Evans Gay — cosponsor (person)
- Larry Lambert — cosponsor (person)
- Madinah Wilson-Anton — cosponsor (person)
- Marie Pinkney — cosponsor (person)
- Michael Ramone — cosponsor (person)
- Paul S. Baumbach — cosponsor (person)
- Ruth Briggs King — cosponsor (person)
- S. Elizabeth Lockman — cosponsor (person)
- Spiros Mantzavinos — cosponsor (person)
- Trey Paradee — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2021-03-04 Introduced and Assigned to Health & Social Services Committee in Senate
introduction, referral-committee - 2021-03-17 Reported Out of Committee (Health & Social Services) in Senate with 5 Favorable
committee-passage, committee-passage-favorable - 2021-03-23 Passed By Senate. Votes: 21 YES
passage - 2021-03-24 Assigned to Health & Human Development Committee in House
introduction, referral-committee - 2021-03-31 Reported Out of Committee (Health & Human Development) in House with 8 Favorable, 6 On Its Merits
committee-passage, committee-passage-favorable - 2021-04-16 Suspension of Rules in House
- 2021-04-22 Passed By House. Votes: 40 YES 1 ABSENT
passage - 2021-06-03 Signed by Governor
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/d85abf5f-969b-41ad-8842-e8aad1d9a2a1. Confidence: reported (aggregated from official Delaware legislature records).